Login
800-633-4743
Login
Back to Credit Category
search for
or search by
Order By Rank
Order By Popularity
Order By Posted Date
Order By Title
10 Items Per Page
20 Items Per Page
40 Items Per Page
60 Items Per Page
80 Items Per Page
100 Items Per Page
Results 1 - 20 of 153
1
2
3
4
5
6
7
8
Things We Do for No Reason™: Avoiding Intravenous Iodinated Contrast Material in Patients With Acute Kidney Injury or Chronic Kidney Disease.
Posted Date: 5/21/2026 7:48:00 PM
Issue: Hospital Medicine - May 2026 - Vol. 24 - No. 11
Editorial Advisor: Joseph R. Sweigart, MD, FACP
Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer.
Posted Date: 12/31/2025 9:47:00 PM
Issue: Cancer Management - December 2025 - Vol. 56 - No. 1
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Primary Results for the Phase III Trial of Toxicity Reduction Using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010).
Posted Date: 12/31/2025 9:47:00 PM
Issue: Cancer Management - December 2025 - Vol. 56 - No. 1
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
With the role of protons being questionable in prostate cancer, breast cancer, and head and neck cancers, the target population narrows.
Ten-Year Survival After Postmastectomy Chest-Wall Irradiation in Breast Cancer.
Posted Date: 12/31/2025 9:47:00 PM
Issue: Cancer Management - December 2025 - Vol. 56 - No. 1
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled Trial.
Posted Date: 10/2/2025 9:12:00 PM
Issue: Cancer Management - September 2025 - Vol. 55 - No. 10
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
A Retrospective Propensity-Matched Study Comparing Whole-Brain Radiotherapy With Simultaneous Integrated Boost to Whole-Brain Radiotherapy Alone for Brain Metastases.
Posted Date: 10/2/2025 7:27:00 PM
Issue: Neurosurgery - September 2025 - Vol. 27 - No. 3
Editorial Advisor: Vadim Dushkin, MD
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging.
Posted Date: 9/9/2025 6:22:00 PM
Issue: Family Medicine - September 2025 - Vol. 55 - No. 6
Editorial Advisor: Janet L. Barrall, MD
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging.
Posted Date: 8/26/2025 9:36:00 PM
Issue: Gastroenterology - August 2025 - Vol. 44 - No. 4
Editorial Advisor: Ingram Roberts, MD, MBA
A Retrospective Propensity-Matched Study Comparing Whole-Brain Radiotherapy With Simultaneous Integrated Boost to Whole-Brain Radiotherapy Alone for Brain Metastases.
Posted Date: 8/22/2025 9:07:00 PM
Issue: Neurology - August 2025 - Vol. 32 - No. 9
Editorial Advisor: Vadim Dushkin, MD
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging.
Posted Date: 8/1/2025 2:20:00 PM
Issue: Hospital Medicine - July 2025 - Vol. 24 - No. 1
Editorial Advisor: C. Monique Lucarelli, MD
Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.
Posted Date: 7/1/2025 12:44:00 AM
Issue: Cancer Management - June 2025 - Vol. 55 - No. 7
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Omitting Regional Nodal Irradiation After Response to Neoadjuvant Chemotherapy.
Posted Date: 7/1/2025 12:44:00 AM
Issue: Cancer Management - June 2025 - Vol. 55 - No. 7
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.
Posted Date: 5/28/2025 8:02:00 PM
Issue: Cancer Management - May 2025 - Vol. 55 - No. 6
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer.
Posted Date: 5/28/2025 8:02:00 PM
Issue: Cancer Management - May 2025 - Vol. 55 - No. 6
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging.
Posted Date: 5/28/2025 7:18:00 PM
Issue: Internal Medicine - May 2025 - Vol. 63 - No. 8
Editorial Advisor: Janet L. Barrall, MD
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging.
Posted Date: 5/20/2025 7:17:00 PM
Issue: Oral & Maxillofacial Surgery - May 2025 - Vol. 43 - No. 8
Editorial Advisor: Jeffrey D. Bennett, DMD
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
Posted Date: 1/31/2025 5:37:00 PM
Issue: Cancer Management - January 2025 - Vol. 55 - No. 2
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Characteristics of Radiation-Induced Brain Tumors: Case Series and Systematic Review.
Posted Date: 1/5/2025 4:39:00 PM
Issue: Neurosurgery - January 2025 - Vol. 26 - No. 7
Editorial Advisor: Raj Murali, MD, FRCS, FAANS, FACS
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.
Posted Date: 12/31/2024 3:23:00 PM
Issue: Cancer Management - December 2024 - Vol. 55 - No. 1
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.
Posted Date: 12/7/2024 4:25:00 AM
Issue: Cancer Management - November 2024 - Vol. 54 - No. 12
Editorial Advisor: Jonathan J. Beitler, MD, MBA, FASTRO
1
2
3
4
5
6
7
8